baber/WOPTO huggingface dataset:
Patent NZ-510310-A (NZ)
Title: Process for preparing N,N,6- trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]-pyridine-3-acetamide and its salts
Inventor: LABRIOLA RAFAEL
IPC: A61K31/435
Filed: 1999-08-04
Abstract: A process for preparing N,N,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide of formula (I) comprises: a) treating the hydroxy ester of formula (X) in a halocarbonated solvent at a temperature of 0-300C with an iminium salt of formula (XIII) formed in situ with thionyl chloride and dimethylformamide, b) subsequently reducing the resulting halogenated compound of formula (XI) with an appropriate reducing agent to form the ester of formula (XII) and c) then reacting the compounds of formula (XII) with dimethylamine in a polyhydroxylated solvent medium at an appropriate temperature.
Patent NZ-510461-A (NZ)
Title: Tire tread having uneven groove walls
Inventor: JANAJREH IBRAHIM MUSTAFA
IPC: B60C11/03
Filed: 2000-07-06
Abstract: A tread for a tire includes at circumferentially extending grooves having side walls contoured with upper and lower waveforms that are relatively staggered, or out of phase. The side walls provide alternating protrusions and recesses relative to a perpendicular reference plane passing through upper edges of the groove. A cavity is provided beneath upper groove edges for the entire circumference of the tread, which imparts flexibility and helps avoid the initiation of rail wear
Patent NZ-511589-A (NZ)
Title: A complex of a chaperone with beta-amyloid and methods employing this complex
Inventor: HOLTZMAN JORDAN
IPC: C07K19/00
Filed: 1999-10-29
Abstract: An isolated complex comprising a chaperone Q2 and a beta-amyloid, such as animal beta-amyloid 1-42, animal beta-amyloid 1-38, human beta-amyloid 1-42, or human beta-amyloid 1-38.
Patent NZ-512872-A (NZ)
Title: Phenylphenanthridines with PDE-IV inhibiting activity
Inventor: GUTTERER BEATE
IPC: A61P11/02
Filed: 2000-01-12
Abstract: Compounds of formula (I) that are active bronchial therapeutic useful for treating airways disorders are disclosed, wherein R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meaning indicated in the specification.
Patent NZ-518930-A (NZ)
Title: Combined agents for treatment of glaucoma
Inventor: YOKOYAMA TOMIHISA
IPC: A61K31/535
Filed: 2000-12-01
Abstract: An  agent for the prophylaxis or treatment of glaucoma comprising  an  angiotensin  II antagonist  of  formula  (I) wherein  the  R1  represents a group selected  from  (Ia)  - (If),  and  at  least one compound selected from  adrenaline receptor  blockers,  prostaglandins and  carbonic  anhydrase inhibitors as active ingredients.
Patent NZ-519353-A (NZ)
Title: Polyurethane foams having improved heat sag and a process for their production
Inventor: CLATTY JAN L
IPC: C08G18/66
Filed: 2002-06-04
Abstract: An isocyanate-reactive component useful for the production of a rigid closed cell polyurethane foam by a RIM process comprising: (a) from 0.5 to 30% by weight of a bio-based polyol, (b) from 5 to 80% by weight of an isocyanate-reactive material having a functionality of at least 1 and a number average molecular weight of from 400 to 10 000, (c) a chain extender or a crosslinking agent, (d) a blowing agent, and (e) a catalyst. The bio-based polyol, or bio-based oil, may be a blown vegetable oil such as soybean oil.
Patent NZ-524386-A (NZ)
Title: Membrane penetrating peptides and uses thereof
Inventor: GUO YONG
IPC: C07K19/00
Filed: 2001-08-23
Abstract: The present disclosure is directed to membrane penetrating peptides useful as in vivo, ex vivo and in vitro intracellular delivery devices for compound of interest. More particularly, the disclosure involves identification of membrane penetrating peptides which may be used as protein carriers for delivery of a compound of interest to cells, to methods of delivering a compound of interest attached to membrane penetrating peptides to cells. The peptide is in the form of a fusion protein for delivering the compound of interest into a cell, comprising the compound of interest and a membrane penetrating peptide derived from a nuclear localization sequence found in a transcription factor, more particularly a Period protein. The peptide comprises a sequence -(X-X-X-X)n- where n is an integer from 1-7 and X is independently selected from arginine, histidine or lysine.
Patent NZ-524469-A (NZ)
Title: Heat pump drier with improved efficiency
Inventor: SCHARPF ERIC WILLIAM
IPC: F26B3/04
Filed: 2003-02-28
Abstract: An apparatus and process including a heat sink exchanger (26) to cool and condense liquid out of a drying gas with a heat transfer surface arranged to exchange heat with a first sub- stream of the drying gas and a heat source heat exchanger (27) arranged to exchange heat with a second sub-stream of a drying gas and arranged in a functionally parallel configuration with said heat sink heat exchanger (26) so that each of said drying gas sub- streams exchanges heat with one of the two said heat transfer surface per cycle through the heat exchange system and a gas movement device (35) for propelling the drying gas through the heat exchanger system in either a forward or reverse flow path direction. The apparatus and process can also include controlling the amount of heat rejected from apparatus (26) based on maintaining the wet bulb of the drying gas nominally constant and controlling the amount of refrigerant in the heat exchanger circuit based on maintaining the dry bulb temperature of the drying gas within certain limits.
Patent NZ-526226-A (NZ)
Title: 1,4-disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers
Inventor: ANAND NITYA
IPC: A61K31/497
Filed: 2001-11-29
Abstract: A compound or its pharmaceutically acceptable salts, amides, enantiomers, diastereoisomers, N-oxides, prodrugs, metabolites or polymorphs has the formula (I) wherein: A is alkyl and R is cinnamyl, optionally substituted benzyl or mono or disubstituted phenyl. The compounds are useful in selectively antagonizing a1 adrenergic receptors and are useful in treating benign prostatic hyperplasia.
Patent NZ-527975-A (NZ)
Title: Modulation of smooth muscle cell proliferation
Inventor: GEESIN JEFFREY C
IPC: C12N5/077
Filed: 2002-03-07
Abstract: A nucleic acid molecule encoding a CUB domain polypeptide comprising an amino acid sequence consisting of the amino acid position 40 to 150 of Figure 1A, a vector comprising the nucleic acid molecule and a polypeptide comprising an amino acid sequence consisting of the amino acid position 40 to 150 of Figure 1A can be used in the manufacture of a medicament for stimulating smooth muscle cell proliferation in non-human tissues and organs. An antibody capable of binding to a CUB domain polypeptide comprising an amino acid sequence consisting of the amino acid position 40 to 150 of Figure 1A can be used in the manufacture of a medicament for treating or preventing any of atherosclerosis, neointimal hyperplasia caused by artery anastomosis or balloon catheter, postangioplasty restenosis caused by arterial stenting after percutaneous transluminal coronary angioplasty. With the proviso that the polypeptide does not comprise the entire amino acid sequence listed in Figure 1A. Also described are nucleic acid molecules encoding a VEGF-X polypeptide comprising an amino acid sequence according to Figure 1A or encoding a CUB domain polypeptide comprising an amino acid sequence consisting of the amino acid position 40 to 150 of Figure 1A, vectors comprising the nucleic acid molecules and the polypeptides can be used in the manufacture of a medicament for treating or preventing urethral dysfunction, bladder dysfunction, sphincter dysfunction or for pelvic floor reconstruction.
Patent NZ-529180-A (NZ)
Title: An activated form of TGF-beta enriched protein fraction made using a small number of short steps thus avoiding significant loss in biological activity
Inventor: MAUBOIS JEAN-LOUIS
IPC: A61K35/20
Filed: 2002-07-12
Abstract: Described is a method for obtaining a highly enriched TGF-beta protein fraction in activated form, from a liquid solution rich in proteins said to be soluble in the aqueous phase of milk and/or of whey. The method comprising the following steps: a) adjusting soluble proteins purified at a concentration between 5 to 30 g/litre of solution; b) precipitating part of the whey proteins by acid treatment of the solution thus obtained to a pH ranging between 4 and 5.5 and at a temperature ranging between 55 DEG C and 68 DEG C; c) carrying out a microfiltration of the treated solution by diafiltration, so as to obtain respectively a microfiltration retentate and a microfiltrate; d) recovering the microfiltration retentate containing the protein fraction highly enriched in TGF-beta and e) drying the microfiltration retentate which has been subjected to diafiltration to obtain a powder highly enriched in TGF-beta.
Patent NZ-536562-A (NZ)
Title: Sample collecting device and mass spectrometry of device
Inventor: WATLING ROGER JOHN
IPC: G01N1/10
Filed: 2003-04-16
Abstract: A sample collection device comprising a support bearing an inert absorbing matrix for a fluid sample is described. The device may or may not have a lancet. Also described for a sample device is a method of using a mass spectrometer in a laboratory where the sample in its matrix is ionised and the plurality of elements is detected. The results may or may not be quantised in relation to the original sample and an internal ionised reference sample may also be used.
Patent NZ-536823-A (NZ)
Title: Improved asphalt emulsions for treatment of road surfaces
Inventor: TAKAMURA KOICHI
Filed: 2002-05-14
Abstract: Disclosed is a composition for rejuvenating asphalt pavement, comprising: (a) asphalt, (b) a cationic surfactant, (c) a recycling agent, (d) a co-agglomerated styrene butadiene rubber latex.
Patent NZ-540556-A (NZ)
Title: Salt whey product and method of making
Inventor: MISTRY VIKRAM V
IPC: A23C19/064
Filed: 2003-11-25
Abstract: A process for the manufacture of a salt whey product is provided. In the dried form the product contains 35-45% salt and 5-15% whey protein and in the liquid form, over 12% salt and over 30% solids. The salt whey product can be used as an ingredient in the manufacture of process cheese products and other food products. The salt whey product provides important functional and nutritional attributes from whey proteins. The salt whey product is prepared by removing fat from the salt whey followed by pasteurising and concentrating.
Patent NZ-551097-A (NZ)
Title: Battery management apparatus
Inventor: LUCINSKY DARREN GRANT
IPC: H02J7/00
Filed: 2006-11-06
Abstract: A method of charging lead acid batteries is provided. The method includes, in order, the steps of: a) applying a first applied voltage to a battery until the open terminal voltage of the battery exceeds a first target voltage, and then disconnecting the first applied voltage, b) applying no charging voltage to the battery for a time exceeding 30 seconds, and monitoring the open terminal voltage of the battery until the voltage falls below a second target voltage, c) connecting a second applied voltage lower than the first applied voltage to the battery until the battery reaches a second target voltage lower than the first target voltage, d) connecting a third applied voltage lower than the second applied voltage to the battery for an extended period of time. An apparatus for performing the method is also provided.
Patent NZ-551367-A (NZ)
Title: Can end with tab for improved accessibility
Inventor: TURNER TIMOTHY
IPC: B65D17/34
Filed: 2005-05-12
Abstract: The can end 10 for a container comprising a curled segment 14 which defines the outer perimeter of the can end, with a chuck wall 15 extending downwards from the curled segment to a central panel 12.. The central panel 12 which is centred about the longitudinal axis of the container, has an interior side, an exterior side, a non-detachable tab which is joined to the panel by a rivet 72, and a displaceable tear panel 20 which is defined by a frangible score 22 and a non-frangible hinge section 26. The tab has a nose end 78 which extends over a portion of the tear panel, and a lift end 70 opposite the nose end and two cut-outs 84 100, which are separated by a central section 76 which extends towards the rivet. The height of the lift end 70 of the tab is kept at a height greater than 1.27mm above the central panel, but below that of the outer curled segment 14.
Patent NZ-551948-A (NZ)
Title: Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
Inventor: BRUMMERHOP HARM
IPC: A61K31/7056
Filed: 2005-06-03
Abstract: Disclosed is a compound of formula I, wherein R1 and R2 are each F or H as long as at least one is F, A is O, NH, CH2, S, or a bond, R6 and R7 are separately groups as described in the specification or may together form a ring, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating type 1 and type 2 diabetes and for lowering blood glucose.
Patent NZ-560239-A (NZ)
Title: An adjustable washer system for building elements including nesting members with eccentric apertures
Inventor: THOMPSON PETER GOODWIN
Filed: 2007-07-30
Abstract: This invention relates to an adjustable washer system for building elements. Particularly, a washer system for a fixing element. The washer system includes a plurality of members of differing size, wherein each member has a body (1, 4, 6) and an aperture (2, 5, 7). The aperture of each member is adapted to receive the body of the next smallest member in a substantially planar nested arrangement; and the aperture of at least one member other than the largest member is located eccentrically within the body of the said member. The side walls of the aperture of the largest member are tapered within the range >0° to 5°.
Patent NZ-563261-A (NZ)
Title: Effectors of innate immunity
Inventor: HANCOCK ROBERT E W
IPC: C12Q1/68
Filed: 2002-12-02
Abstract: An isolated peptide comprising the general formula X1LX2X2X3KX4X2X5X3PX3X1 (SEQ ID NO: 11), wherein X1 is one or two of D, E, S, T or N, X2 is one of P, G or D, X3 is one of G, A, V, L, I or Y, X4 is one of R, K or H and X5 is one of S, T, C, M or R. Also disclosed is the use of the isolated peptides in treating inflammatory conditions of sepsis.
Patent NZ-571423-A (NZ)
Title: Infant safety suit comprising at least one pocket which extends over substantially the entire front half of torso
Inventor: MOSS LINDA M
IPC: A41B13/06
Filed: 2007-03-05
Abstract: An article (10) of clothing for a baby is disclosed. The article (10) includes a shell portion (12) that substantially encloses the torso and arms of the baby (18). The arms of the baby (18) are generally free to move within the shell portion (12). The shell portion (12) has at least one restraining member (32) that is located internally for engagement with each arm or hand (12) of the baby (18). This restraining member (32) substantially prevents the baby (18) from moving its arms within the shell portion (12) to the other side of its body. The restraining member (32) comprises a pocket which extends over the entire respective front half of the torso. The lower arm and hand (42) are received within the pocket.
Patent NZ-573207-A (NZ)
Title: Sole for shoes of the waterproof and vapor-permeable type, and shoe provided with said sole
Inventor: POLEGATO MORETTI MARIO
IPC: A43B7/12
Filed: 2007-05-31
Abstract: Disclosed is a sole for shoes, of the waterproof and vapour-permeable type. The sole includes a lower element made of plastic material, on which a tread provided with multiple through holes is formed. The sole includes a membrane which is impermeable to water and permeable to water vapour and is arranged above the lower element so as to be superimposed on the through holes. The membrane is joined perimetrically and hermetically to the sole so as to avoid the rise of liquids through the sole. The sole has means for protecting the membrane comprising individual vapour-permeable protective elements, each arranged so as to block a corresponding through hole. The protective elements are arranged below the membrane so as to be superimposed on the area of the holes. The lower element forms, for each through hole, an undercut region for preventing downward extraction for each protective element. The membrane overlaps the through holes and is joined perimetrically and hermetically to the lower element to form a single perimetric seal.
Patent NZ-583589-A (NZ)
Title: Electric fence monitoring module with monitoring window synchronised with fence pulses
Inventor: WOODHEAD ROBERT CHARLES BRYAN
IPC: H04B3/00
Filed: 2008-08-26
Abstract: Disclosed is a monitoring module (109) for monitoring pulses applied to an electric fence (101) by an energiser module. The monitoring module (109) is arranged to monitor, within a dynamic time period, the pulses applied to the fence (101). The monitoring module is also arranged to adjust the dynamic time period until an applied pulse is detected by the monitoring module (109) within the dynamic time period.
Patent NZ-586552-A (NZ)
Title: Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
Inventor: CHO IL HWAN
IPC: C07D239/96
Filed: 2009-01-08
Abstract: The disclosure relates to a quinazoline-2,4-dione derivative of chemical formula (I) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. Also disclosed is a process for the preparation of these quinazoline-2,4-dione derivatives. The disclosure further relates to medical compositions for the prophylaxis and treatment of cranial nerve disease containing a compound of formula (I) as an active component.
Patent NZ-586593-A (NZ)
Title: System for currency conversion with table relating merchants to primary account numbers and exchange rates
Inventor: BECK PHILIP D
IPC: G06Q30/00
Filed: 2008-12-30
Abstract: 586593 Disclosed is a system (10) for performing dynamic currency conversion between a merchant (24) and a customer (22). The merchant (24) has a merchant account with a merchant financial institution in a local currency and a merchant ID number associated with the account. The customer (22) has a payment card issued by a payment card issuer in a card-issuer currency which differs from the local currency. The system (10) is comprised of a processor (14), memory accessible by the processor (14) and electronics for receiving transaction approval requests (28) from the merchant (24). The requests (28) include the merchant ID number, the payment card number and a transaction amount in the local currency. The memory includes information stored in table form containing payment card attributes associated with various payment card numbers, and contains attributes associated with various merchants. Attributes associated with a specified merchant (24) and customer (22) are used to determine a total markup rate (30) for currency conversion. The processor (14) is programmed to convert the local currency to the card-issuer currency and also determine the total markup fees associated with the transaction upon receiving a transaction approval request (28) from a merchant (24) in the local currency. Ranges of successively numbered payment cards which share common attributes are grouped and stored with a common payment card identifier for each range. Upon receiving a transaction approval request (28) from a merchant (24), the processor (14) determines whether the payment card number falls within one of the ranges. If so, the processor (14) uses the attributes associated with the common payment card identifier when determining the total markup rate (30) rather than individual records for each payment card.
Patent NZ-589197-A (NZ)
Title: Probe head having gauge acoustically insulated from window
Inventor: SKEIDSVOLL JARLE
IPC: G01N21/85
Filed: 2009-04-30
Abstract: A system for removing deposits from measuring instruments measuring chosen characteristics of a fluid medium contained in a pipe or container. The measuring instrument includes a window (10) and a first surface (12) having contact with the medium. The first surface is positioned on one end defining a probe head (2) of an elongated member (13) adapted to extend through the wall of the pipe or container. The outer end of the member is positioned outside the wall. The cleaning system includes an acoustic transducer positioned on the other end of the elongated member. The acoustic transducer is acoustically coupled to the elongated member so as to couple acoustic energy thereto. The acoustic energy propagating along the member to the end (2,12) of the probe is in contact with the fluid inside the pipe or container, the resulting vibrations of which remove any contaminations from the window by inducing cavitation.
Patent NZ-594092-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C08H8/00
Filed: 2009-12-16
Abstract: Disclosed herein is a method of reducing recalcitrance in cellulosic or lignocellulosic materials, the method comprising: contacting, in a mixture, an irradiated first cellulosic or lignocellulosic material having a first level of recalcitrance with one or more compounds comprising one or more naturally occurring, nonradioactive group 5, 6, 7, 8, 9, 10 or 11 elements (preferably Mn, Fe, Co, Ni, Cu or Zn), to produce a second cellulosic or lignocellulosic material having a second level of recalcitrance lower than the first level of recalcitrance.
Patent NZ-594786-A (NZ)
Title: Convertible boats
Inventor: CRAZE MATTHEW KINGSLEY
IPC: B63B17/02
Filed: 2010-01-15
Abstract: 594786 Disclosed is a boat (10) having a selectively convertible hard top canopy (24). The boat includes opposing side walls (14) with gunwales (16) thereon, a foredeck (18) between the side walls and below the gunwales, an extensible and retractable windscreen (20) in front and around the sides of the foredeck, and a helm console (22) behind the foredeck. The hard top canopy is pivotally connected to the side walls of the boat via hinged arms (26), and is pivotally and selectively convertible between first, second and third configurations (see figures 1-3, respectively). In the first configuration the windscreen is retracted below or just above the gunwales, and the hard top is collapsed forwardly to overlap the retracted windscreen and/or the gunwales to form a platform covering the foredeck. This configuration reduces the overall height of the boat, making it easier to store in a small carport and reducing drag when towed by a vehicle. In the second configuration the windscreen is extended above the gunwales, and the hard top is partially erected to overlap the extended windscreen, so that together the windscreen and hard top form an enclosure over, above and around the front and sides of the foredeck. This configuration provides the passengers shelter from sea spray and harsh weather. In the third configuration the windscreen is retracted below or just above the gunwales, and the hard top is fully erected over and above the helm console. This configuration provides the passengers shade from the sun. A method of selectively covering different areas of a boat is also disclosed.